Evolutionary Mechanism of Immunological Cross-Reactivity Between Different GII.17 Variants

• Main Authors: Yueting Zuo, Liang Xue, Junshan Gao, Yingyin Liao, Yanhui Liang, Yueting Jiang, Weicheng Cai, Zhiwei Qin, Jiale Yang, Jumei Zhang, Juan Wang, Moutong Chen, Yu Ding, Qingping Wu
• Format: Article
• Language: English
• Published: Frontiers Media S.A. 2021-04-01
• Series: Frontiers in Microbiology
• Subjects: norovirus; GII.17; capsid protein; immunogenicity; evolutionary mechanism
• Online Access: https://www.frontiersin.org/articles/10.3389/fmicb.2021.653719/full

Human norovirus is regarded as the leading cause of epidemic acute gastroenteritis with GII.4 being the predominant genotype during the past decades. In the winter of 2014/2015, the GII.17 Kawasaki 2014 emerged as the predominant genotype, surpassing GII.4 in several East Asian countries. Hence, the influence of host immunity response on the continuous evolution of different GII.17 variants needs to be studied in depth. Here, we relate the inferences of evolutionary mechanisms of different GII.17 variants with the investigation of cross-reactivity and cross-protection of their respective antisera using the expression of norovirus P particles in Escherichia coli. The cross-reactivity assay showed that the antisera of previous strains (GII.17 A and GII.17 B) reacted with recent variants (GII.17 C and GII.17 D) at high OD values from 0.8 to 1.16, while recent variant antisera cross-reacting with previous strains were weak with OD values between 0.26 and 0.56. The cross-protection assay indicated that the antisera of previous strains had no inhibitory effect on recent variants. Finally, mutations at amino acids 353–363, 373–384, 394–404, and 444–454 had the greatest impact on cross-reactivity. These data indicate that the recent pandemic variants GII.17 C and GII.17 D avoided the herd immunity effect of previous GII.17 A and GII.17 B strains through antigenic variation.